UTI (179900.KQ) Stock Price
UTI Price
Revenue has compounded at 23.9% per year over the past 11 years to 19.97 B KRW. Earnings per share have declined at 39.5% per year over the last 5 years. UTI's net margin stands at -187.2%, down from 2.8% several years earlier. UTI currently offers a dividend yield of about 2.12%. The payout ratio is around 61% of earnings.
UTI stock price
UTI business model & stock analysis
Frequently asked questions about UTI
5 analysts currently rate the UTI stock: 4 recommend buying, 1 holding and 0 selling.
Converted at the current exchange rate, the UTI share trades at 1.57 EUR (2,355.00 KRW).
The revenue cannot currently be calculated for UTI.
The expected profit of UTI is 37.42 B KRW. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of UTI is currently 1.20. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the UTI stock.
The P/S cannot be calculated for UTI currently.
The Eulerpool Quality Score for UTI is 1/10.
The ISIN of UTI is KR7179900006. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of UTI is 179900.KQ. The ticker symbol is used to trade UTI shares on the stock exchange.
UTI stock
UTI Peer Group
UTI FIGI
All fundamentals and in-depth analysis of UTI
Our stock analysis for UTI stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of UTI. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.